Bizarre Patents
A vest or belt is integrally formed with tubular, pet receiving passageways which extend around the wearer's body and terminate in pocket-like chambers for feeding and retrieval.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 6017542 | Nucleotide and amino acid sequences of canine herpesvirus GD and uses therefor Disclosed and claimed are nucleotides for genes encoding the canine herpesvirus (CHV) gB, gC and gD homologues. These genes encode polypeptides of 879, 459 and 345 amino acids, respectively, which are also disclosed and claimed. The genes are useful as DN... | 01/25/2000 |
| 5968775 | Hepatitis C virus infected cell systems The present invention is directed to extracorporeal cell systems infected with hepatitis C virus (HCV). The present invention also relates to products of such cell systems and their use as vaccines and in immunoassays. Methods whereby HCV-infected extraco... | 10/19/1999 |
| 5928862 | Competitive homogeneous assay Methods and compositions for performing assays for target polynucleotide strands include contacting a sample with a reagent which includes a first and a second polynucleotide probe. The first and second probes are capable of assuming a first position wher... | 07/27/1999 |
| 5846766 | Oxytocin receptor and DNA coding therefor The present invention relates to a receptor for a posterior pituitary hormone, oxytocin; a DNA sequence encoding for the receptor; a recombinant DNA molecule containing the DNA sequence and a transformant comprising the recombinant DNA molecule. The prese... | 12/08/1998 |
| 5840316 | Ryegrass pollen allergen The present invention provides nucleic acid sequences coding for two ryegrass pollen allergen Lol p Ib family members, purified Lol p Ib.1 and Lol p Ib.2 proteins and fragments thereof, methods of producing recombinant Lol p Ib.1 or Lol p Ib.2 or at least... | 11/24/1998 |
| 5811265 | Hybrid immunoglobulin-thrombolytic enzyme molecules which specifically bind a thrombus, and methods of their production and use Hybrid immunoglobulin-enzyme molecules are provided which are composed of antibodies, or derivatives or fragments thereof, which specifically bind an arterial or venous thrombus that are operably linked to the enzymatically active portions of thrombolytic... | 09/22/1998 |
| 5795741 | Coccidiosis poultry vaccine This invention relates to novel Eimeria proteins with immunogenic properties as well as to DNA sequences encoding these proteins. These proteins can be administered to poultry thereby protecting the birds against coccidiosis. In addition the DNA encoding ... | 08/18/1998 |
| 5783192 | Recombinant feline herpesvirus vaccine The present invention is concerned with a Feline herpesvirus (FHV) mutant comprising a heterologous gene introduced into an insertion-region of the FHV genome. The invention also relates to a vector vaccine comprising such an FHV mutant which expresses a ... | 07/21/1998 |
| 5736362 | Ryegrass pollen allergen The present invention provides nucleic acid sequences coding for two ryegrass pollen allergen Lol p Ib family members, purified Lol p Ib.1 and Lol p Ib.2 proteins and fragments thereof, methods of producing recombinant Lol p Ib.1 or Lol p Ib.2 or at least... | 04/07/1998 |
| 5733549 | Peptides including amino acid sequences selected from lipoprotein (a) and apolipoprotein (a), antibodies recognizing these amino acid sequences, and methods of determination using these antibodies Amino acid sequences having specificity as lipoprotein (a) and low homology with LDL and plasminogen are selected from the amino acid sequence of lipoprotein (a), and antibodies to lipoprotein (a) which recognize these amino acid sequences specifically ar... | 03/31/1998 |
| 5721119 | Ryegrass pollen allergen The present invention provides nucleic acid sequences coding for two ryegrass pollen allergen Lol p Ib family members, purified Lol p Ib.1 and Lol p Ib.2 proteins and fragments thereof, methods of producing recombinant Lol p Ib.1 or Lol p Ib.2 or at least... | 02/24/1998 |
| 5708147 | Mononuclear leukocyte directed endothelial adhesion molecule associated with atherosclerosis The invention relates to novel endothelial cell-leukocyte adhesion molecules designated ATHERO-ELAM. ATHERO-ELAM molecules are expressed on cultured endothelial cells stimulated with bacterial LPS and selectively mediate the binding of monocytes to the en... | 01/13/1998 |
| 5698671 | Metalloproteinase peptides Inappropriate degradation of extracellular matrix molecules by metalloproteinases plays an important role in a wide variety of pathologic conditions including neoplasia and arthritis. The present invention is an isolated protein of approximately 23,000 da... | 12/16/1997 |
| 5695956 | Clostridium perfingens type a enterotoxin toxoid and methods of preparation and use as a vaccine and therapeutic agent Escherichia coli strains that produce recombinant Clostridium perfringens type A enterotoxin toxoids from a Clostridium perfringens type A enterotoxin gene fragment encoding the Clostridium perfringens type A enterotoxin binding domain subcloned into an e... | 12/09/1997 |
| 5688920 | Nucleotide and amino acid sequences for canine herpesvirus GB, GC and GD and uses therefor Disclosed and claimed are nucleotides for genes encoding the canine herpesvirus (CHV) gB, gC and gD homologues. These genes encode polypeptides of 879, 459 and 345 amino acids, respectively, which are also disclosed and claimed. The genes are useful as DN... | 11/18/1997 |
| 5683901 | Method of producing RNA viruses from cDNA The present invention relates to methods for producing RNA virus cDNA, methods for producing viable, RNA virus and viable, RNA virus produced by those methods. The invention also related to a novel RNA virus cDNA, recombinant DNA molecules containing that... | 11/04/1997 |
| 5681695 | Method for increasing specificity in competitive immunoassays The invention is an improved immunoassay and method for detection of antibody to hepatitis B core antigen (anti-HBc). The improved assay comprises the addition of a reducing agent to decrease the number of false positive reactions in the assay.... | 10/28/1997 |
| 5679342 | Hepatitis C virus infected cell systems The present invention is directed to extracorporeal cell systems infected with hepatitis C virus (HCV). The present invention also relates to products of such cell systems and their use as vaccines and in immunoassays. Methods whereby HCV-infected extraco... | 10/21/1997 |
| 5656475 | Use of lymphocytes transformed with herpesvirus saimiri in a process for replicating viruses of the HIV type which cause immune deficiency A process is disclosed for replicating viruses of the HIV type which cause immune deficiency, in which process lymphocytes are employed which have been transformed with herpesvirus saimiri.... | 08/12/1997 |
| 5656485 | Eimeria antigenic composition which elicits antibodies against avian coccidiosis This invention relates to novel recombinant antigenic proteins of avian coccidiosis, and fragments thereof containing antigenic determinants, and to the genes that encode the antigenic peptides. This invention also relates to vaccines made using the novel... | 08/12/1997 |
| 5652119 | Recombinant feline herpesvirus vaccine The present invention is concerned with a Feline herpesvirus (FHV) mutant comprising a heterologous gene introduced into an insertion-region of the FHV genome. The invention also relates to a vector vaccine comprising such an FHV mutant which expresses a ... | 07/29/1997 |
| 5622928 | Glia activation factor and its production Disclosed are (1) a novel glia activating factor which has glial cell growth promoting activity; (2) a glia activating factor containing a polypeptide; (3) a DNA coding for a glia activating factor; (4) a host transformed with a vector containing the DNA ... | 04/22/1997 |
| 5616322 | Sperm antigen corresponding to a sperm zona binding protein autoantigenic epitope The present invention involves DNA encoding a mammalian Sp 17 protein, particularly human Sp17 protein, or antigenic peptides which are fragments thereof, along with said antigenic fragments. These proteins and peptides are useful as immunocontraceptive a... | 04/01/1997 |
| 5614195 | Coccidiosis poultry vaccine This invention relates to novel Eimeria proteins with immunogenic properties as well as to DNA sequences encoding these proteins. These proteins can be administered to poultry thereby protecting the birds against coccidiosis. In addition the DNA encoding ... | 03/25/1997 |
| 5610032 | AMPA-binding human GluR1 receptors Described herein are isolated polynucleotides which code for an AMPA-type human CNS receptor, designated the human GluR1B receptor. The receptor is characterized structurally and the construction and use of cell lines expressing the receptor is disclosed.... | 03/11/1997 |
| 5609869 | Hybrid immunoglobulin-thrombolytic enzyme molecules which specifically bind a thrombus, and methods of their production and use Hybrid immunoglobulin-enzyme molecules are provided which are composed of antibodies, or derivatives or fragments thereof, which specifically bind an arterial or venous thrombus that are operably linked to the enzymatically active portions of thrombolytic... | 03/11/1997 |
| 5601822 | γ, δ T cell receptor and methods for detection The present invention provides purified polypeptides which comprise at least a portion of a δ T cell receptor polypeptide, a γ T cell receptor polypeptide, a γ, δ T cell receptor complex or a γ, γ T cell receptor complex. Substances capable of formi... | 02/11/1997 |
| 5597571 | Eimeria antigenic composition which elicits antibodies against avian coccidiosis This invention relates to novel recombinant antigenic proteins of avian coccidiosis, and fragments thereof containing antigenic determinants, and to the genes that encode the antigenic peptides. This invention also relates to vaccines made using the novel... | 01/28/1997 |
| 5595885 | Matrix metalloproteinase inhibitor peptides The present invention is an isolated protein of 21,600 Da which binds to both latent and activated type IV collagenase with high affinity at 1:1 molar stoichiometry, thereby abolishing enzyme activity. The protein is purified by affinity chromatography on... | 01/21/1997 |
| 5591439 | Recombinant cytomegalovirus vaccine The present invention provides a non-defective adenovirus recombinant expression system for the expression of the HCMV gB subunit and for the expression of non-structural immediate-early exon 4 proteins, said recombinant HCMV-expressing adenovirus being u... | 01/07/1997 |
| 5591574 | Probes, diagnostic method and immunization method based on papillomavirus types HPV 49 and HPV 50 The invention relates to papillomavirus probes derived from new DNA-HPVs deposited with the C.N.C.M. on May 6, 1988, under the following filing numbers: ______________________________________ PGEM 4 HPV49: I-754 PSP ... | 01/07/1997 |
| 5587166 | Vaccine against Pasteurella A vaccine against Pasteurella comprising a proteinaceous material isolated from Pasteurella grown under iron-restricted conditions, but not from Pasteurella grown under normal conditions in vitro, which reacts in an immunoblotting test against the serum o... | 12/24/1996 |
| 5580719 | Method for producing RNA viruses from cDNA The present invention relates to methods for producing RNA virus cDNA, methods for producing viable, RNA virus and viable, RNA virus produced by those methods. The invention also related to a novel RNA virus cDNA, recombinant DNA molecules containing that... | 12/03/1996 |
| 5580740 | Antihuman pulmonary adenocarcinoma monoclonal antibody An antihuman pulmonary adenocarcinoma monoclonal antibody ALC-390 and a process for producing thereof are disclosed. This monoclonal antibody, which belongs to IgG class and is reactive with human pulmonary adenocarcinoma cell membranes and recognizes pro... | 12/03/1996 |
| 5573918 | Process and reagent for specific determination of pancreatic alpha amylase The present invention provides a process for the specific determination of pancreatic alpha-amylase in the presence of salivary alpha-amylase in body fluids, especially in serum, plasma, duodenal juice or urine, by reaction with a system for the detection... | 11/12/1996 |
| 5573919 | Assay using an absorbent material An assay for detecting an analyte which comprises applying a sample containing analyte to a surface of an absorbent material having at least one binder for the analyte supported on at least a portion of the surface. The absorbent material has a porosity w... | 11/12/1996 |
| 5571514 | Fibronectin binding protein as well as its preparation The present invention relates to a new recombinant hybrid-DNA-molecule comprising nucleotide sequence from S. aureus coding for a protein, or polypeptide, having fibronectin binding properties.... | 11/05/1996 |
| 5556751 | Selective amplification system using Q-ଲ replicase Mutant forms of midivariant RNA are disclosed which are replicated efficiently by the enzyme Qଲ replicase in the presence of an agent(s) which is useful for the real time, quantitative detection of the accumulating RNA products. This agent(s) also s... | 09/17/1996 |
| 5556943 | Cell adhesion protein, gene coding for the same, process for preparing the same and carrier onto which the same is immobilized A sheep LFA-3 protein and derivertires thereof, and derivertives of a human LFA-3 protein, gene coding for the proteins, and processes for preparing the proteins. Said proteins have high affinity for human T-cells.... | 09/17/1996 |
| 5552143 | Recombinant cytomegalovirus vaccine The present invention provides a non-defective adenovirus recombinant expression system for the expression of the HCMV gB subunit, an immunogenic fragment of the gB subunit, and for the expression of non-structural immediate-early exon 4 proteins, said re... | 09/03/1996 |
